Clinical Trials Directory

Trials / Completed

CompletedNCT01131260

Fetal ST Segment and T Wave Analysis in Labor

A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11,108 (actual)
Sponsor
The George Washington University Biostatistics Center · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along with the existing electronic fetal monitor used to measure the baby's heart rate and the mother's contractions during birth. The specific purpose of this research study is to see if this new instrument (fetal STAN monitor) will have an impact on newborn health.

Detailed description

A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN): Fetal ECG analysis of the ST segment (STAN) is now FDA-approved and clinically available in the United States as an adjunct for the interpretation of electronic fetal heart rate patterns. There have been a number of randomized controlled trials as well as observational studies in Europe documenting utility of this modality in terms of reducing fetal acidosis at birth, and decreasing the need for operative vaginal delivery. However, despite these endorsements, there remain concerns with the application of the technology to the United States. None of the randomized trials were performed in the United States where patient case-mix and obstetrical practice, such as the use of fetal scalp pH, differ from Europe, which may affect the impact of this technology on perinatal outcomes. Moreover, the results of the European studies are not uniformly positive. This protocol describes a randomized controlled trial of the STAN technology as an adjunct to electronic fetal heart rate monitoring versus fetal heart rate monitoring alone.

Conditions

Interventions

TypeNameDescription
DEVICEfetal STAN monitorThe STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.

Timeline

Start date
2010-11-01
Primary completion
2014-04-01
Completion
2014-08-01
First posted
2010-05-26
Last updated
2019-07-15
Results posted
2019-04-05

Locations

13 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01131260. Inclusion in this directory is not an endorsement.